Physicians and health care groups have lined up to support the Value in Health Care Act, which could create new incentives to adopt value-based care.
Health care organizations are lining up to support federal legislation that could create new incentives for physicians and health care organizations to adopt value-based care.
Federal lawmakers introduced the Value in Health Care Act of 2023 and a number of physician and medical groups quickly announced their endorsements.
The legislation “would make commonsense changes to Medicare’s Alternative Payment Models (APMs) program to incentivize greater participation in value-based health programs.” It would help increase participation in accountable care organizations (ACOs) that are designed to improve quality of care and health outcomes for seniors, while lower costs, said an announcement from Representative Suzan DelBene (D, Oregon), a cosponsor of the bill. Additional sponsors are Representatives Darin LaHood (R, Illinois), Kim Schrier, MD, (D, Washington), Brad Wenstrup, DPM (R, Ohio), Earl Blumenauer (D, Oregon), and Larry Bucshon, MD (R, Indiana).
Representative Suzan DelBene (D, Oregon) is a cosponsor of the Value in Health Care Act, which could create new incentives to adopt value-based care.
“Physicians and hospitals participating in Alternative Payment Models are leading the changes our health care system needs to focus on value instead of volume,” DelBene said in the announcement. "Providers should be paid based on the quality of the care they deliver, not the quantity of services. The Value in Health Care Act would encourage more providers to join these models and accelerate this change, leading to improved quality of care and health outcomes for seniors."
The lawmakers’ announcement said the Value in Health Care Act would make the following changes to the APM and ACO parameters:
If approved, the legislation would extend the 5% advanced APM incentive payment as practices transition from fee-for-service care to value-based care, according to the Medical Group Management Association (MGMA).
“In light of another round of proposed cuts to Medicare physician reimbursement, ensuring group practices have the necessary support to succeed in value-based care arrangements is paramount,” MGMA Senior Vice President of Government Affairs Anders Gilberg said in a statement. “MGMA looks forward to working with Congress to ensure the passage of this crucial piece of legislation.”
The bill also would freeze the 50% revenue threshold that physicians in value-based care models must meet to qualify for the incentive payments, according to the American Medical Association (AMA).
The legislation would give the HHS secretary the authority to further increase the revenue threshold but at a more gradual pace—no more than 5% in a given year, AMA President Jesse M. Ehrenfeld, MD, MPH, said in a statement.
“These proposed policies would grant HHS the needed flexibility to adjust the financial risk at a pace that enables more physicians to participate in APMs, while building on the tremendous movement toward value-based care," Ehrenfeld said.
MGMA and AMA both were part of a joint letter of support published July 27 by the American Hospital Association. The additional supporters on that letter were Accountable for Health, American Academy of Family Physicians, American Academy of Orthopaedic Surgeons, the American College of Physicians, America’s Essential Hospitals, America’s Physician Groups, AMGA, the Association of American Medical Colleges, Federation of American Hospitals, Healthcare Leadership Council, Health Care Transformation Task Force, the National Association of ACOs, and National Rural Health Association Premier Inc.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More